U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948630) titled 'Hemogram Parameter Changes With Sepsis Filter' on April 21.
Brief Summary: Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflammatory cytokines. Data obtained from hemograms, such as platelet lymphocytosis ratio, are used in the diagnosis or prognosis of many diseases. This study focuses on the change in hemogram rates in patients who received hemofiltration and sepsis filters.
Study Start Date: Jan. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Platelet Abnormality
Renal Failure
Immu...